osimertinib
astrazeneca
['sclc', 'lcsm,(-blcsm)', 'nsclc', 'lung', 'osimertinib']
 happening now #asco23 new partners for egfr mutant #lungcancer featuring very own presenting trial of neoadjuvant osimertinib in early stage nsclc mentored by #lcsm 
Thoracic Onc @ZSFGCare | Asst Director DEIA @UCSFCancer | #Boricua🇵🇷🌙 @LatinXOncology | 🎓@medupr @uprm🐾 @NCSP_UCSF | equity cancer disparities | Views mine